# Cariprazine for Clozapine-Induced Urinary Incontinence in Treatment-Resistant Depression: A Case Report

**Authors:** Ana Carolina Pires, Isabela Faria, Joana Marques Pinto, Miguel Bajouco, Joana Andrade

PMC · DOI: 10.7759/cureus.77582 · Cureus · 2025-01-17

## TL;DR

A patient with depression experienced urinary incontinence from clozapine, but symptoms improved when cariprazine was reintroduced.

## Contribution

This case report suggests cariprazine may help manage clozapine-induced urinary incontinence in treatment-resistant depression.

## Key findings

- The patient developed urinary incontinence after reducing cariprazine dosage.
- Reintroducing cariprazine led to significant improvement in urinary incontinence.
- No other interventions or medication changes were needed for symptom improvement.

## Abstract

Urinary incontinence (UI) is an adverse effect associated with clozapine treatment. Several management options are available, including adjuvant medication. We describe the case of a woman in her 50s with a history of major depressive disorder and a current severe depressive episode with psychotic symptoms. The case is discussed, and a review of the relevant literature is presented, examining the use of cariprazine in the management of clozapine-induced UI. Cariprazine was initiated as a first-line treatment, followed by clozapine several months later. Following a reduction in the dose of cariprazine, the patient developed UI. Physical examination was unremarkable, and laboratory investigations were normal. No additional interventions were required. No other medication was altered, and upon reintroduction of cariprazine, the patient's UI improved significantly. Although a single case is inadequate for establishing definitive conclusions, this case report indicates the need for further investigation into the potential of cariprazine in addressing clozapine-induced UI.

## Linked entities

- **Chemicals:** cariprazine (PubChem CID 11154555), clozapine (PubChem CID 135398737)
- **Diseases:** major depressive disorder (MONDO:0002009)

## Full-text entities

- **Diseases:** psychotic symptoms (MESH:D011618), major (MESH:D004830), Depression (MESH:D003866), UI (MESH:D014549)
- **Chemicals:** Clozapine (MESH:D003024), Cariprazine (MESH:C533287)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11830278/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11830278/full.md

---
Source: https://tomesphere.com/paper/PMC11830278